日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SURG-33. INTRAOPERATIVE ULTRASSOUND X SODIUM FLUORESCEIN FOR GLIOMA SURGERY: WHICH IS BETTER?

SURG-33. 神经胶质瘤手术中术中超声与荧光素钠:哪种更好?

McClendon, B J; Politzer, R M; Christian, E; Fernandez, E S; Campos Paiva, Aline Lariessy; Araujo, João Luiz Vitorino; Lovato, Renan Maximillian; dos Santos, Gabriel José; de de Mendonça, André Luca Barongeno; de Andrade, Hallison Rodrigues; de Oliveira, Jean Gonçalves; Veiga, José Carlos Esteves

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

COVID-19 急性后遗症 (PASC) 患者 CD16+ 单核细胞中 SARS-CoV-2 S1 蛋白的持续存在可长达感染后 15 个月

Bruce K Patterson ,Edgar B Francisco ,Ram Yogendra ,Emily Long ,Amruta Pise ,Hallison Rodrigues ,Eric Hall ,Monica Herrera ,Purvi Parikh ,Jose Guevara-Coto ,Timothy J Triche ,Paul Scott ,Saboor Hekmati ,Dennis Maglinte ,Xaiolan Chang ,Rodrigo A Mora-Rodríguez ,Javier Mora

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning

利用机器学习解码基于免疫的 COVID-19 严重程度和慢性程度预测

Bruce K Patterson, Jose Guevara-Coto, Ram Yogendra, Edgar B Francisco, Emily Long, Amruta Pise, Hallison Rodrigues, Purvi Parikh, Javier Mora, Rodrigo A Mora-Rodríguez

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

到第 14 天,重症 COVID-19 患者中 CCR5 抑制可减少炎症细胞因子、增加 CD8 T 细胞并降低血浆中的 SARS-CoV2 RNA

Bruce K Patterson, Harish Seethamraju, Kush Dhody, Michael J Corley, Kazem Kazempour, Jay Lalezari, Alina P S Pang, Christopher Sugai, Eisa Mahyari, Edgar B Francisco, Amruta Pise, Hallison Rodrigues, Helen L Wu, Gabriela M Webb, Byung S Park, Scott Kelly, Nader Pourhassan, Alina Lelic, Lama Kdouh,